Department of Endocrinology and Metabolism, Dr. Cesar Milstein Hospital, 951 La Rioja Str., Buenos Aires, Argentina.
Hormones (Athens). 2012 Jul-Sep;11(3):350-5. doi: 10.14310/horm.2002.1364.
To examine the association between thyroid profile and morbidity/mortality (MM) in hospitalized older patients.
This is a retrospective study of patients over the age of 60 yr admitted to the Dr. Cesar Milstein Hospital between 2009 and 2010 and who had thyroid function tests (TFT). The patients were grouped as per their thyroid tests and their clinical characteristics and MM was associated with their TFT. High MM was defined as mortality, intensive care unit (ICU) requirement or prolonged hospital stay (>18 days, 75th percentile), and mortality assessed during an 18-month follow-up period after their hospital discharge.
Out of 2599 older patients admitted to our hospital, 7% had TFT performed for various reasons. The patients who had TFT were mostly women and presented in a more serious clinical condition compared to the rest of the patients. The patients were grouped as per their thyroid values as follows: 61% of them had a non-thyroidal illness, 25% were euthyroid,7% had overt hyperthyroidism, 5% overt hypothyroidism and 1% had subclinical hyper- or hypothyroidism. The hypothyroid patients had a worse clinical outcome compared to the others. Patients with increased MM exhibited higher TSH and lower TT4 (p<0.005). Short-term MM (OR=2.0,95%CI=1.1-3.6, p<0.01) was associated with the decrease of TT4 adjusted by age, sex, T3 and TSH, while for long-term MM the increase in TSH (OR=1.6,95%CI 1.1-2.3, p<0.05) was also significant.
Among hospitalized older patients who had TFT tests, low TT4 and high TSH were associated with a worse prognosis. We propose that TFT be used as an additional tool in assessing MM in elderly hospitalized patients.
探讨甲状腺功能与住院老年患者发病率/死亡率(MM)的关系。
这是一项回顾性研究,纳入 2009 年至 2010 年期间在 Dr. Cesar Milstein 医院住院且接受甲状腺功能检查(TFT)的 60 岁以上患者。根据甲状腺检查结果及其临床特征将患者分组,并将 MM 与 TFT 相关联。高 MM 定义为死亡率、入住重症监护病房(ICU)或住院时间延长(>18 天,第 75 百分位数),并在出院后 18 个月的随访期间评估死亡率。
在 2599 名住院老年患者中,有 7%因各种原因进行了 TFT。与其他患者相比,接受 TFT 的患者大多为女性,临床表现更为严重。根据甲状腺值将患者分为以下几类:61%为非甲状腺疾病患者,25%为甲状腺功能正常患者,7%为显性甲状腺功能亢进症患者,5%为显性甲状腺功能减退症患者,1%为亚临床甲状腺功能亢进或减退症患者。与其他患者相比,甲状腺功能减退症患者的临床结局更差。高 MM 患者的 TSH 更高,TT4 更低(p<0.005)。短期 MM(OR=2.0,95%CI=1.1-3.6,p<0.01)与 TT4 降低相关,调整年龄、性别、T3 和 TSH 后,而对于长期 MM,TSH 升高(OR=1.6,95%CI 1.1-2.3,p<0.05)也具有显著意义。
在接受 TFT 检查的住院老年患者中,TT4 降低和 TSH 升高与预后较差相关。我们建议将 TFT 用作评估老年住院患者 MM 的附加工具。